United States Healthcare Equipment & Supplies

Novocure Ltd (NVCR)

Track

Track

Novocure Ltd experienced significant insider trading activity recently, with eleven transactions totaling approximately 2.78 million dollars in sales. Executives and officers offloaded shares, reflecting a net negative value of 1.55 million dollars. These divestments occurred alongside the latest earnings report, while the stock price saw a 6.4 percent decline over the past ninety days.
Ticker: NVCR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Novocure Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
NICOLAS LEUPIN Officer Officer
Transaction date
Proposed sale
Price
285.92
Quantity 72,871
Value US$3,790,925
4.0
Leonard Frank X Chief Executive Officer Officer
Transaction date
Sale
Price
10.33
Quantity 57,399 -9.0%
Value US$4,602,223
4.0
Leonard Frank X Chief Executive Officer Officer
Transaction date
Sale
Price
212.00
Quantity 95,650 -25.4%
Value US$2,035,793
4.0
FRANCIS LEONARD Officer Officer
Transaction date
Proposed sale
Price
17.93
Quantity 34,273
Value US$614,635
2.5
HILLEMAN JERYL L Non-Executive Director
Transaction date
Sale
Price
15.77
Quantity 2,945 -17.5%
Value US$46,445
2.5
LEUNG GABRIEL Non-Executive Director
Transaction date
Sale
Price
15.77
Quantity 2,945 -3.2%
Value US$46,445
3.3
VERNON W ANTHONY Non-Executive Director
Transaction date
Sale
Price
15.77
Quantity 2,945 -1.5%
Value US$46,445
2.1
Ocean Allyson J Non-Executive Director
Transaction date
Sale
Price
15.77
Quantity 2,945 -20.6%
Value US$46,445
2.6
Scannell Timothy J Non-Executive Director
Transaction date
Sale
Price
15.77
Quantity 2,945 -17.1%
Value US$46,445
2.1
Stafford Kristin Non-Executive Director
Transaction date
Sale
Price
15.77
Quantity 2,945 -20.6%
Value US$46,445
3.5
Hung David Non-Executive Director
Transaction date
Sale
Price
15.77
Quantity 2,945 -12.6%
Value US$46,445
2.8
Paravasthu Mukund Chief Operating Officer Officer
Transaction date
Sale
Price
13.77
Quantity 43,246 -37.3%
Value US$595,670
2.8
MUKUND PARAVASTHU Officer Officer
Transaction date
Proposed sale
Price
13.77
Quantity 43,246
Value US$595,682
2.6
Leupin Nicolas Former Chief Medical Officer Officer
Transaction date
Sale
Price
13.31
Quantity 1,100 -1.1%
Value US$14,636
4.0
Leonard Frank X Chief Executive Officer Officer
Transaction date
Sale
Price
13.31
Quantity 5,607 -1.1%
Value US$74,603
2.8
Paravasthu Mukund Chief Operating Officer Officer
Transaction date
Sale
Price
13.31
Quantity 5,377 -4.4%
Value US$71,543
2.6
Brackmann Christoph Chief Financial Officer Officer
Transaction date
Sale
Price
13.31
Quantity 6,412 -3.4%
Value US$85,314
2.4
Weinberg Uri Chf Medical and Innovation Ofr Officer
Transaction date
Sale
Price
13.31
Quantity 6,412 -2.3%
Value US$85,314
2.4
Puri Michal Nath Chief Human Resources Officer Officer
Transaction date
Sale
Price
13.31
Quantity 1,100 -0.5%
Value US$14,636
2.6
CHRISTOPH BRACKMANN Officer Officer
Transaction date
Proposed sale
Price
13.31
Quantity 6,412
Value US$85,314
2.4
URI WEINBERG Officer Officer
Transaction date
Proposed sale
Price
13.31
Quantity 6,412
Value US$85,314
2.8
MUKUND PARAVASTHU Officer Officer
Transaction date
Proposed sale
Price
13.31
Quantity 5,377
Value US$71,543
4.0
FRANCIS LEONARD Officer Officer
Transaction date
Proposed sale
Price
13.31
Quantity 5,607
Value US$74,603
2.2
DOYLE WILLIAM F Executive Chairman Executive Director
Transaction date
Sale
Price
13.43
Quantity 21,330 -6.1%
Value US$286,436
2.2
DOYLE WILLIAM F Executive Chairman Executive Director
Transaction date
Sale
Price
12.79
Quantity 50,557 -12.6%
Value US$646,447
2.2
WILLIAM DOYLE Officer; Director Executive Director
Transaction date
Proposed sale
Price
12.98
Quantity 71,887
Value US$932,885
2.8
Paravasthu Mukund Chief Operating Officer Officer
Transaction date
Sale
Price
13.49
Quantity 408 -0.5%
Value US$5,505
4.0
Leonard Frank X Chief Executive Officer Officer
Transaction date
Sale
Price
13.49
Quantity 7,232 -2.0%
Value US$97,581
2.4
Weinberg Uri Chf Medical and Innovation Ofr Officer
Transaction date
Sale
Price
13.33
Quantity 3,272 -1.4%
Value US$43,607
4.0
FRANCIS LEONARD Officer Officer
Transaction date
Proposed sale
Price
13.49
Quantity 7,232
Value US$97,581
2.4
URI WEINBERG Officer Officer
Transaction date
Proposed sale
Price
13.33
Quantity 3,272
Value US$43,607
2.8
Paravasthu Mukund Chief Operating Officer Officer
Transaction date
Sale
Price
13.66
Quantity 1,555 -2.0%
Value US$21,247
2.6
Leupin Nicolas Former Chief Medical Officer Officer
Transaction date
Sale
Price
13.66
Quantity 1,029 -1.0%
Value US$14,060
2.4
Puri Michal Nath Chief Human Resources Officer Officer
Transaction date
Sale
Price
13.66
Quantity 1,441 -0.9%
Value US$19,690
4.0
Leonard Frank X Chief Executive Officer Officer
Transaction date
Sale
Price
13.66
Quantity 9,734 -2.8%
Value US$133,003
2.4
Weinberg Uri Chf Medical and Innovation Ofr Officer
Transaction date
Sale
Price
13.84
Quantity 7,461 -3.4%
Value US$103,257
4.0
FRANCIS LEONARD Officer Officer
Transaction date
Proposed sale
Price
13.66
Quantity 9,734
Value US$133,003
2.4
URI WEINBERG Officer Officer
Transaction date
Proposed sale
Price
13.84
Quantity 7,461
Value US$103,257
4.2
Cordova Ashley Chief Executive Officer Officer
Transaction date
Purchase
Price
12.22
Quantity 81,550 +22.9%
Value US$996,859
2.6
Brackmann Christoph Chief Financial Officer Officer
Transaction date
Purchase
Price
11.50
Quantity 5,000 +3.7%
Value US$57,500
2.6
Brackmann Christoph Chief Financial Officer Officer
Transaction date
Purchase
Price
11.60
Quantity 5,000 +3.8%
Value US$58,000
2.6
Brackmann Christoph Chief Financial Officer Officer
Transaction date
Purchase
Price
11.63
Quantity 10,000 +8.3%
Value US$116,300
2.6
Scannell Timothy J Non-Executive Director
Transaction date
Sale
Price
17.32
Quantity 999 -14.2%
Value US$17,299
2.1
Stafford Kristin Non-Executive Director
Transaction date
Sale
Price
17.28
Quantity 999 -24.6%
Value US$17,259
2.5
LEUNG GABRIEL Non-Executive Director
Transaction date
Sale
Price
17.31
Quantity 999 -1.2%
Value US$17,297
2.4
Madden Martin J. Non-Executive Director
Transaction date
Sale
Price
17.19
Quantity 999 -5.1%
Value US$17,176
3.5
Hung David Non-Executive Director
Transaction date
Sale
Price
17.30
Quantity 999 -7.6%
Value US$17,280
3.3
VERNON W ANTHONY Non-Executive Director
Transaction date
Sale
Price
17.35
Quantity 999 -0.6%
Value US$17,329
2.1
Ocean Allyson J Non-Executive Director
Transaction date
Sale
Price
17.29
Quantity 999 -24.6%
Value US$17,269
2.5
HILLEMAN JERYL L Non-Executive Director
Transaction date
Sale
Price
17.26
Quantity 999 -15.2%
Value US$17,247
4.0
Leonard Frank X EVP, Pres., Novocure Oncology Officer
Transaction date
Planned sale
Price
19.01
Quantity 1,879 -1.1%
Value US$35,722
4.0
Leonard Frank X EVP, Pres., Novocure Oncology Officer
Transaction date
Planned sale
Price
17.99
Quantity 6,600 -3.7%
Value US$118,733
4.0
Leonard Frank X EVP, Pres., Novocure Oncology Officer
Transaction date
Planned sale
Price
17.22
Quantity 21,717 -10.9%
Value US$373,958
4.0
FRANCIS LEONARD Officer Officer
Transaction date
Proposed sale
Price
19.11
Quantity 30,196
Value US$577,046
2.8
MUKUND PARAVASTHU Officer Officer
Transaction date
Proposed sale
Price
17.91
Quantity 592
Value US$10,604
2.8
Paravasthu Mukund Chief Operating Officer Officer
Transaction date
Sale
Price
17.91
Quantity 592 -0.7%
Value US$10,604
4.0
Leonard Frank X EVP, Pres., Novocure Oncology Officer
Transaction date
Sale
Price
18.54
Quantity 2,527 -1.7%
Value US$46,841
2.8
Paravasthu Mukund Chief Operating Officer Officer
Transaction date
Sale
Price
18.54
Quantity 250 -0.8%
Value US$4,634
2.4
Weinberg Uri Chief Innovation Officer Officer
Transaction date
Sale
Price
18.92
Quantity 268 -0.2%
Value US$5,071
4.2
Cordova Ashley Chief Executive Officer Officer
Transaction date
Sale
Price
18.54
Quantity 2,053 -1.0%
Value US$38,055
4.0
FRANCIS LEONARD Officer Officer
Transaction date
Proposed sale
Price
18.54
Quantity 2,527
Value US$46,841
2.8
MUKUND PARAVASTHU Officer Officer
Transaction date
Proposed sale
Price
18.54
Quantity 250
Value US$4,634
2.4
URI WEINBERG Officer Officer
Transaction date
Proposed sale
Price
18.92
Quantity 268
Value US$5,071
4.2
ASHLEY CORDOVA Officer Officer
Transaction date
Proposed sale
Price
18.54
Quantity 2,053
Value US$38,055
3.7
WILHELMUS GROENHUYSEN Officer Officer
Transaction date
Proposed sale
Price
18.54
Quantity 3,165
Value US$58,667
4.0
Leonard Frank X EVP, Pres., Novocure Oncology Officer
Transaction date
Sale
Price
18.28
Quantity 2,770 -1.9%
Value US$50,648
2.8
Paravasthu Mukund Chief Operating Officer Officer
Transaction date
Sale
Price
18.28
Quantity 368 -1.2%
Value US$6,729
2.4
Weinberg Uri Chief Innovation Officer Officer
Transaction date
Sale
Price
18.31
Quantity 311 -0.2%
Value US$5,695
2.4
Weinberg Uri Chief Innovation Officer Officer
Transaction date
Sale
Price
18.78
Quantity 4,326 -2.5%
Value US$81,254
4.2
Cordova Ashley Chief Executive Officer Officer
Transaction date
Sale
Price
18.28
Quantity 2,341 -1.1%
Value US$42,804
2.4
URI WEINBERG Officer Officer
Transaction date
Proposed sale
Price
18.75
Quantity 4,637
Value US$86,949
2.8
MUKUND PARAVASTHU Officer Officer
Transaction date
Proposed sale
Price
18.28
Quantity 368
Value US$6,729
4.2
ASHLEY CORDOVA Officer Officer
Transaction date
Proposed sale
Price
18.28
Quantity 2,341
Value US$42,803
3.7
WILHELMUS GROENHUYSEN Officer Officer
Transaction date
Proposed sale
Price
18.28
Quantity 3,202
Value US$58,546
4.0
FRANCIS LEONARD Officer Officer
Transaction date
Proposed sale
Price
18.28
Quantity 2,770
Value US$50,647
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-23 2026-07-23 PrS Proposed sale
2.6
NICOLAS LEUPIN

Officer

Officer
72,871
285.92
US$3,790,925 		72,871 285.92 US$3,790,925
2026-06-05 2026-06-04 S Sale
4.0
Leonard Frank X

Chief Executive Officer

Officer
57,399 -9.0%
10.33
US$4,602,223 		57,399 -9.0% 10.33 US$4,602,223
2026-06-05 2026-06-04 S Sale
4.0
Leonard Frank X

Chief Executive Officer

Officer
95,650 -25.4%
212.00
US$2,035,793 		95,650 -25.4% 212.00 US$2,035,793
2026-06-04 2026-06-04 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
34,273
17.93
US$614,635 		34,273 17.93 US$614,635
2026-06-03 2026-06-02 S Sale
2.5
HILLEMAN JERYL L
Non-Executive Director
2,945 -17.5%
15.77
US$46,445 		2,945 -17.5% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
2.5
LEUNG GABRIEL
Non-Executive Director
2,945 -3.2%
15.77
US$46,445 		2,945 -3.2% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
3.3
VERNON W ANTHONY
Non-Executive Director
2,945 -1.5%
15.77
US$46,445 		2,945 -1.5% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
2.1
Ocean Allyson J
Non-Executive Director
2,945 -20.6%
15.77
US$46,445 		2,945 -20.6% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
2.6
Scannell Timothy J
Non-Executive Director
2,945 -17.1%
15.77
US$46,445 		2,945 -17.1% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
2.1
Stafford Kristin
Non-Executive Director
2,945 -20.6%
15.77
US$46,445 		2,945 -20.6% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
3.5
Hung David
Non-Executive Director
2,945 -12.6%
15.77
US$46,445 		2,945 -12.6% 15.77 US$46,445
2026-03-05 2026-03-05 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
43,246 -37.3%
13.77
US$595,670 		43,246 -37.3% 13.77 US$595,670
2026-03-05 2026-03-05 PrS Proposed sale
2.8
MUKUND PARAVASTHU

Officer

Officer
43,246
13.77
US$595,682 		43,246 13.77 US$595,682
2026-03-05 2026-03-04 S Sale
2.6
Leupin Nicolas

Former Chief Medical Officer

Officer
1,100 -1.1%
13.31
US$14,636 		1,100 -1.1% 13.31 US$14,636
2026-03-05 2026-03-04 S Sale
4.0
Leonard Frank X

Chief Executive Officer

Officer
5,607 -1.1%
13.31
US$74,603 		5,607 -1.1% 13.31 US$74,603
2026-03-05 2026-03-04 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
5,377 -4.4%
13.31
US$71,543 		5,377 -4.4% 13.31 US$71,543
2026-03-05 2026-03-04 S Sale
2.6
Brackmann Christoph

Chief Financial Officer

Officer
6,412 -3.4%
13.31
US$85,314 		6,412 -3.4% 13.31 US$85,314
2026-03-05 2026-03-04 S Sale
2.4
Weinberg Uri

Chf Medical and Innovation Ofr

Officer
6,412 -2.3%
13.31
US$85,314 		6,412 -2.3% 13.31 US$85,314
2026-03-05 2026-03-04 S Sale
2.4
Puri Michal Nath

Chief Human Resources Officer

Officer
1,100 -0.5%
13.31
US$14,636 		1,100 -0.5% 13.31 US$14,636
2026-03-04 2026-03-04 PrS Proposed sale
2.6
CHRISTOPH BRACKMANN

Officer

Officer
6,412
13.31
US$85,314 		6,412 13.31 US$85,314
2026-03-04 2026-03-04 PrS Proposed sale
2.4
URI WEINBERG

Officer

Officer
6,412
13.31
US$85,314 		6,412 13.31 US$85,314
2026-03-04 2026-03-04 PrS Proposed sale
2.8
MUKUND PARAVASTHU

Officer

Officer
5,377
13.31
US$71,543 		5,377 13.31 US$71,543
2026-03-04 2026-03-04 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
5,607
13.31
US$74,603 		5,607 13.31 US$74,603
2026-03-05 2026-03-03 S Sale
2.2
DOYLE WILLIAM F

Executive Chairman

Executive Director
21,330 -6.1%
13.43
US$286,436 		21,330 -6.1% 13.43 US$286,436
2026-03-05 2026-03-03 S Sale
2.2
DOYLE WILLIAM F

Executive Chairman

Executive Director
50,557 -12.6%
12.79
US$646,447 		50,557 -12.6% 12.79 US$646,447
2026-03-03 2026-03-03 PrS Proposed sale
2.2
WILLIAM DOYLE

Officer; Director

Executive Director
71,887
12.98
US$932,885 		71,887 12.98 US$932,885
2026-03-03 2026-03-02 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
408 -0.5%
13.49
US$5,505 		408 -0.5% 13.49 US$5,505
2026-03-03 2026-03-02 S Sale
4.0
Leonard Frank X

Chief Executive Officer

Officer
7,232 -2.0%
13.49
US$97,581 		7,232 -2.0% 13.49 US$97,581
2026-03-03 2026-03-02 S Sale
2.4
Weinberg Uri

Chf Medical and Innovation Ofr

Officer
3,272 -1.4%
13.33
US$43,607 		3,272 -1.4% 13.33 US$43,607
2026-03-02 2026-03-02 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
7,232
13.49
US$97,581 		7,232 13.49 US$97,581
2026-03-02 2026-03-02 PrS Proposed sale
2.4
URI WEINBERG

Officer

Officer
3,272
13.33
US$43,607 		3,272 13.33 US$43,607
2026-03-03 2026-02-27 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
1,555 -2.0%
13.66
US$21,247 		1,555 -2.0% 13.66 US$21,247
2026-03-03 2026-02-27 S Sale
2.6
Leupin Nicolas

Former Chief Medical Officer

Officer
1,029 -1.0%
13.66
US$14,060 		1,029 -1.0% 13.66 US$14,060
2026-03-03 2026-02-27 S Sale
2.4
Puri Michal Nath

Chief Human Resources Officer

Officer
1,441 -0.9%
13.66
US$19,690 		1,441 -0.9% 13.66 US$19,690
2026-03-03 2026-02-27 S Sale
4.0
Leonard Frank X

Chief Executive Officer

Officer
9,734 -2.8%
13.66
US$133,003 		9,734 -2.8% 13.66 US$133,003
2026-03-03 2026-02-27 S Sale
2.4
Weinberg Uri

Chf Medical and Innovation Ofr

Officer
7,461 -3.4%
13.84
US$103,257 		7,461 -3.4% 13.84 US$103,257
2026-02-27 2026-02-27 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
9,734
13.66
US$133,003 		9,734 13.66 US$133,003
2026-02-27 2026-02-27 PrS Proposed sale
2.4
URI WEINBERG

Officer

Officer
7,461
13.84
US$103,257 		7,461 13.84 US$103,257
2025-09-08 2025-09-05 B Purchase
4.2
Cordova Ashley

Chief Executive Officer

Officer
81,550 +22.9%
12.22
US$996,859 		81,550 +22.9% 12.22 US$996,859
2025-07-30 2025-07-29 B Purchase
2.6
Brackmann Christoph

Chief Financial Officer

Officer
5,000 +3.7%
11.50
US$57,500 		5,000 +3.7% 11.50 US$57,500
2025-07-30 2025-07-29 B Purchase
2.6
Brackmann Christoph

Chief Financial Officer

Officer
5,000 +3.8%
11.60
US$58,000 		5,000 +3.8% 11.60 US$58,000
2025-07-30 2025-07-29 B Purchase
2.6
Brackmann Christoph

Chief Financial Officer

Officer
10,000 +8.3%
11.63
US$116,300 		10,000 +8.3% 11.63 US$116,300
2025-06-04 2025-06-03 S Sale
2.6
Scannell Timothy J
Non-Executive Director
999 -14.2%
17.32
US$17,299 		999 -14.2% 17.32 US$17,299
2025-06-04 2025-06-03 S Sale
2.1
Stafford Kristin
Non-Executive Director
999 -24.6%
17.28
US$17,259 		999 -24.6% 17.28 US$17,259
2025-06-04 2025-06-03 S Sale
2.5
LEUNG GABRIEL
Non-Executive Director
999 -1.2%
17.31
US$17,297 		999 -1.2% 17.31 US$17,297
2025-06-04 2025-06-03 S Sale
2.4
Madden Martin J.
Non-Executive Director
999 -5.1%
17.19
US$17,176 		999 -5.1% 17.19 US$17,176
2025-06-04 2025-06-03 S Sale
3.5
Hung David
Non-Executive Director
999 -7.6%
17.30
US$17,280 		999 -7.6% 17.30 US$17,280
2025-06-04 2025-06-03 S Sale
3.3
VERNON W ANTHONY
Non-Executive Director
999 -0.6%
17.35
US$17,329 		999 -0.6% 17.35 US$17,329
2025-06-04 2025-06-03 S Sale
2.1
Ocean Allyson J
Non-Executive Director
999 -24.6%
17.29
US$17,269 		999 -24.6% 17.29 US$17,269
2025-06-04 2025-06-03 S Sale
2.5
HILLEMAN JERYL L
Non-Executive Director
999 -15.2%
17.26
US$17,247 		999 -15.2% 17.26 US$17,247
2025-06-04 2025-06-02 PlS Planned sale
4.0
Leonard Frank X

EVP, Pres., Novocure Oncology

Officer
1,879 -1.1%
19.01
US$35,722 		1,879 -1.1% 19.01 US$35,722
2025-06-04 2025-06-02 PlS Planned sale
4.0
Leonard Frank X

EVP, Pres., Novocure Oncology

Officer
6,600 -3.7%
17.99
US$118,733 		6,600 -3.7% 17.99 US$118,733
2025-06-04 2025-06-02 PlS Planned sale
4.0
Leonard Frank X

EVP, Pres., Novocure Oncology

Officer
21,717 -10.9%
17.22
US$373,958 		21,717 -10.9% 17.22 US$373,958
2025-06-02 2025-06-02 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
30,196
19.11
US$577,046 		30,196 19.11 US$577,046
2025-05-05 2025-05-05 PrS Proposed sale
2.8
MUKUND PARAVASTHU

Officer

Officer
592
17.91
US$10,604 		592 17.91 US$10,604
2025-05-05 2025-05-03 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
592 -0.7%
17.91
US$10,604 		592 -0.7% 17.91 US$10,604
2025-03-04 2025-03-03 S Sale
4.0
Leonard Frank X

EVP, Pres., Novocure Oncology

Officer
2,527 -1.7%
18.54
US$46,841 		2,527 -1.7% 18.54 US$46,841
2025-03-04 2025-03-03 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
250 -0.8%
18.54
US$4,634 		250 -0.8% 18.54 US$4,634
2025-03-04 2025-03-03 S Sale
2.4
Weinberg Uri

Chief Innovation Officer

Officer
268 -0.2%
18.92
US$5,071 		268 -0.2% 18.92 US$5,071
2025-03-04 2025-03-03 S Sale
4.2
Cordova Ashley

Chief Executive Officer

Officer
2,053 -1.0%
18.54
US$38,055 		2,053 -1.0% 18.54 US$38,055
2025-03-03 2025-03-03 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
2,527
18.54
US$46,841 		2,527 18.54 US$46,841
2025-03-03 2025-03-03 PrS Proposed sale
2.8
MUKUND PARAVASTHU

Officer

Officer
250
18.54
US$4,634 		250 18.54 US$4,634
2025-03-03 2025-03-03 PrS Proposed sale
2.4
URI WEINBERG

Officer

Officer
268
18.92
US$5,071 		268 18.92 US$5,071
2025-03-03 2025-03-03 PrS Proposed sale
4.2
ASHLEY CORDOVA

Officer

Officer
2,053
18.54
US$38,055 		2,053 18.54 US$38,055
2025-03-03 2025-03-03 PrS Proposed sale
3.7
WILHELMUS GROENHUYSEN

Officer

Officer
3,165
18.54
US$58,667 		3,165 18.54 US$58,667
2025-03-03 2025-02-28 S Sale
4.0
Leonard Frank X

EVP, Pres., Novocure Oncology

Officer
2,770 -1.9%
18.28
US$50,648 		2,770 -1.9% 18.28 US$50,648
2025-03-03 2025-02-28 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
368 -1.2%
18.28
US$6,729 		368 -1.2% 18.28 US$6,729
2025-03-03 2025-02-28 S Sale
2.4
Weinberg Uri

Chief Innovation Officer

Officer
311 -0.2%
18.31
US$5,695 		311 -0.2% 18.31 US$5,695
2025-03-03 2025-02-28 S Sale
2.4
Weinberg Uri

Chief Innovation Officer

Officer
4,326 -2.5%
18.78
US$81,254 		4,326 -2.5% 18.78 US$81,254
2025-03-03 2025-02-28 S Sale
4.2
Cordova Ashley

Chief Executive Officer

Officer
2,341 -1.1%
18.28
US$42,804 		2,341 -1.1% 18.28 US$42,804
2025-02-28 2025-02-28 PrS Proposed sale
2.4
URI WEINBERG

Officer

Officer
4,637
18.75
US$86,949 		4,637 18.75 US$86,949
2025-02-28 2025-02-28 PrS Proposed sale
2.8
MUKUND PARAVASTHU

Officer

Officer
368
18.28
US$6,729 		368 18.28 US$6,729
2025-02-28 2025-02-28 PrS Proposed sale
4.2
ASHLEY CORDOVA

Officer

Officer
2,341
18.28
US$42,803 		2,341 18.28 US$42,803
2025-02-28 2025-02-28 PrS Proposed sale
3.7
WILHELMUS GROENHUYSEN

Officer

Officer
3,202
18.28
US$58,546 		3,202 18.28 US$58,546
2025-02-28 2025-02-28 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
2,770
18.28
US$50,647 		2,770 18.28 US$50,647
Explore more

More insider trading research around Novocure Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America